Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
VIDEO
AstraZeneca Buys Ardea Biosciences for $1.26 Billion: Hot Trends
By Brittany Umar
Apr 23, 2012 10:31 AM EDT
STOCKS
AstraZeneca Buys Ardea Biosciences for $1.26B: Hot Trends
By Brittany Umar
Apr 23, 2012 8:03 AM EDT
MUTUAL FUNDS
10 Stocks That Fidelity Funds Are Buying
By Frank Byrt
Apr 11, 2012 6:00 AM EDT
STOCKS
Thursday's Top 10 Articles, Videos on TheStreet
By TheStreet Staff
Feb 9, 2012 12:28 PM EST
INVESTING
5 Stocks Insiders Love Right Now
By Roberto Pedone
Feb 9, 2012 10:12 AM EST
STOCKS
Insiders Trading WEN, UA, LULU, RDEA
By Jonathan Moreland
Feb 6, 2012 8:30 AM EST
MARKETS
Ardea Stock Falls On Unusually High Volume (RDEA)
By TheStreet Wire
Feb 1, 2012 10:11 AM EST
STOCKS
Biocryst's Gout Drug Fails to Impress
By Adam Feuerstein
Oct 5, 2011 11:49 AM EDT
MARKETS
Ardea Stock Hits New 52-Week Low (RDEA)
By TheStreet Wire
Aug 8, 2011 10:25 AM EDT
MUTUAL FUNDS
Health Funds See Value in Lagging Sector
By Stan Luxenberg
Feb 3, 2011 10:06 AM EST
STOCKS
Insiders Trading RDEA, JPM, AMTD, RLOG
By Jonathan Moreland
Jan 25, 2011 10:32 AM EST
STOCKS
General Electric: New Targets, Estimates
By TheStreet Staff
Jan 25, 2011 10:08 AM EST
STOCKS
BioCryst Tripped Up by Downgrade
By Michael Baron
Sep 23, 2010 4:15 PM EDT
INVESTING
This Week's 'Barron's' Roundup
By Stockpickr Staff
Apr 17, 2010 4:56 PM EDT
STOCKS
FDA Refuses to Approve Savient Gout Drug
By Adam Feuerstein
Aug 2, 2009 8:25 PM EDT
STOCKS
Sequenom Fallout Hits Hedge Funds
By Adam Feuerstein
Apr 30, 2009 2:47 PM EDT
STOCKS
Did Ardea's HIV Drug Catch the Bouquet?
By Adam Feuerstein
Feb 9, 2009 10:56 AM EST
STOCKS
Glaxo Buys Rights to Idenix HIV Drug
By Samantha Shaddock
Feb 6, 2009 2:17 PM EST
